Insider Shareholders with Direct Ownership of Eidos Therapeutics, Inc. (EIDX)
This section provides a comprehensive overview of the insiders with direct ownership of Eidos Therapeutics, Inc. (EIDX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Eidos Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bridge Bio Pharma, Inc.
> 10% Shareholder |
14,428,836 | 0 | 1,000 $122,010 | 1 |
Jan 26, 2021
Added 99.99%
|
|
Uma Sinha
Chief Scientific Officer |
0 | 331,525 | 0 $0 | 7 |
Jan 26, 2021
Reduced 100.0%
|
|
Franco Valle
Senior Vice President, Finance |
15,069 | 15,513 | 0 $0 | 10 |
Jan 12, 2021
Reduced 100.0%
|
|
Cameron Turtle
Chief Business Officer |
33,794 | 104,403 | 0 $0 | 6 |
Jan 26, 2021
Reduced 100.0%
|
|
Jonathan C Fox
Officer |
0 | 380,967 | 0 $0 | 2 |
Jan 26, 2021
Reduced 100.0%
|